Risedronate is a bisphosphonate medication primarily used to treat and prevent osteoporosis and manage Paget's disease of bone by inhibiting osteoclast-mediated bone resorption. To support the rigorous… Read more








Risedronate is a bisphosphonate medication primarily used to treat and prevent osteoporosis and manage Paget's disease of bone by inhibiting osteoclast-mediated bone resorption. To support the rigorous demands of pharmaceutical quality control, this category provides a comprehensive selection of Risedronate reference standards, including the active pharmaceutical ingredient and its associated impurities. These high-quality compounds are essential for accurate impurity profiling and method validation, enabling laboratories to ensure compliance with pharmacopeial standards during routine testing. In addition to related compounds and synthesis intermediates, stable isotope labelled versions are available for use as internal standards in mass spectrometry-based quantification, facilitating precise analysis even in complex biological matrices. Utilizing these analytical tools allows for the reliable detection and monitoring of potential degradation products, ensuring consistent performance in the evaluation of therapeutic formulations.